Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MLNR | O43193 | 1/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | GHSR | Q92847 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 5/20 | 0.87 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.87 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.87 |
| ▸ | RECQL | P46063 | 4/20 | 0.87 |
| ▸ | TP53 | P04637 | 3/20 | 0.87 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.87 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.87 |
| ▸ | TUBB4A | P04350 | 13/20 | 0.85 |
| ▸ | TUBB | P07437 | 13/20 | 0.85 |
| ▸ | TUBA3C | P0DPH7 | 13/20 | 0.85 |
| ▸ | TUBA1B | P68363 | 13/20 | 0.85 |
| ▸ | TUBA4A | P68366 | 13/20 | 0.85 |
| ▸ | TUBB4B | P68371 | 13/20 | 0.85 |
| ▸ | TUBB3 | Q13509 | 13/20 | 0.85 |
| ▸ | TUBB2A | Q13885 | 13/20 | 0.85 |
| ▸ | TUBB8 | Q3ZCM7 | 13/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Vindesine SCHEMBL13287292 | 1.00 | MLNR (1.00) | MLNRPTGS2KCNH2GHSRMEN1 | |
| Vindesine SCHEMBL6061457 | 1.00 | MLNR (1.00) | MLNRPTGS2KCNH2GHSRMEN1 | |
| Vindesine SCHEMBL14317791 | 1.00 | MLNR (1.00) | MLNRPTGS2KCNH2GHSRMEN1 | |
| Vindesine SCHEMBL13524311 | 1.00 | MLNR (1.00) | MLNRPTGS2KCNH2GHSRMEN1 | |
| Vindesine SCHEMBL13529131 | 1.00 | MLNR (1.00) | MLNRPTGS2KCNH2GHSRMEN1 | |
| Vindesine SCHEMBL15866615 | 1.00 | MLNR (1.00) | MLNRPTGS2KCNH2GHSRMEN1 | |
| Vindesine SCHEMBL15187454 | 1.00 | MLNR (1.00) | MLNRPTGS2KCNH2GHSRMEN1 | |
| Vindesine SCHEMBL21229943 | 1.00 | MLNR (1.00) | MLNRPTGS2KCNH2GHSRMEN1 | |
| Vindesine SCHEMBL20622397 | 1.00 | MLNR (1.00) | MLNRPTGS2KCNH2GHSRMEN1 | |
| Vindesine SCHEMBL13211594 | 1.00 | MLNR (1.00) | MLNRPTGS2KCNH2GHSRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 107083 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144890-A1 | ANTIBODY DRUG CONJUGATE COMPRISING NMT INHIBITOR CONJUGATED TO AN ANTIBODY | MyricX Pharma Limited (GB) | 2026-05-28 | — | — | US | claimed |
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| EP-3607938-B1 | PHARMACEUTICAL COMPOSITION | SOVIC BRKICIC LJILJANA (HR) | 2026-05-27 | — | — | EP | claimed |
| CN-116209439-B | Cereblon protein modulators | Saint Jude Children's Research Hospital Ltd. (US) | 2026-05-26 | — | — | CN | claimed |
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| US-12630593-B2 | Method of killing leukemia cells by administration of recombinant'Y3 proteins | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-05-19 | — | — | US | claimed |
| WO-2025136820-A9 | POLY-ANTIGEN CYTOKINE-RECEPTOR COMPLEXES (PACCS), COMPOSITIONS, AND METHODS OF USE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2026-05-15 | — | — | WO | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| WO-2026101236-A1 | PEPTIDES SPECIFICALLY BINDING TO CCR8, AND USE THEREOF | 경희대학교 산학협력단 | 2026-05-15 | — | — | WO | claimed |
| EP-4739310-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) INHIBITOR COMBINATIONS AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2026-05-13 | — | — | EP | claimed |
| US-4388305-A | LESS TOXIC THAN VINCRISTINE OR VINDESINE | OMNICHEM S.A. (BE) | 1983-06-14 | — | — | US | claimed |
| EP-0007206-B1 | PHENETHANOLAMINES, THEIR FORMULATIONS, PREPARATION AND USE | ELI LILLY AND COMPANY (US) | 1983-02-23 | — | — | EP | claimed |
| EP-0009996-B1 | PREPARATION OF VINDESINE MONOSULFATE | ELI LILLY AND COMPANY (US) | 1983-02-23 | — | — | EP | claimed |
| WO-1983000150-A1 | GLYCOSAMINOGLYCAN DRUG COMPLEXES | WALTON, ALAN, G. | 1983-01-20 | — | — | WO | claimed |
| US-4259242-A | FREE FROM HEMISULFATE AND DISULFATE | ELI LILLY AND COMPANY (US) | 1981-03-31 | — | — | US | claimed |
| EP-0014053-A1 | Synthesis of vindesine; vincaleukoblastine compounds | ELI LILLY AND COMPANY (US) | 1980-08-06 | — | — | EP | claimed |
| US-4210584-A | Vindesine synthesis | ELI LILLY AND COMPANY (US) | 1980-07-01 | — | — | US | claimed |
| US-4208414-A | Vinblastine in rheumatoid arthritis | ELI LILLY AND COMPANY (US) | 1980-06-17 | — | — | US | claimed |
| EP-0009996-A1 | Preparation of vindesine monosulfate | ELI LILLY AND COMPANY (US) | 1980-04-16 | — | — | EP | claimed |
| EP-0007206-A1 | Phenethanolamines, their formulations, preparation and use | ELI LILLY AND COMPANY (US) | 1980-01-23 | — | — | EP | claimed |